RGLS logo

Regulus Therapeutics (RGLS) EV/EBITDA

EV/EBITDA

-1.62
+0.13+7.43%

Thu, 13 Mar 2025 23:23:29 GMT


Summary


Performance

RGLS EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherRGLSvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

RGLS EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday+7.4%-7.3%-5.3%
1 m1 month-30.6%+31.0%+20.5%
3 m3 months+19.0%-19.1%-14.6%
6 m6 months+38.6%-27.4%-14.6%
ytdytd+14.3%-14.3%-10.8%
1 y1 year-65.3%+133.3%-42.5%
5 y5 years-394.6%+877.4%-72.9%

RGLS EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-30.6%-1.75+7.4%
3 m3-month-0.92-76.1%-2.03+20.2%
6 m6-month-0.92-76.1%-3.02+46.4%
1 y1-year-0.92-76.1%-5.86+72.3%
3 y3-year0.87-286.2%-5.86+72.3%
5 y5-year0.91-278.0%-8.60+81.2%
alltimeall time0.91-278.0%-30.72+94.7%

Regulus Therapeutics EV/EBITDA History

DateValue
2025
-1.62(-14.3%)
2024
-1.89(+1353.8%)
2023
-0.13(-31.6%)
2022
-0.19(-176.0%)
2021
0.25(-105.2%)
2020
-4.80(-9700.0%)
2019
0.05(-120.0%)
DateValue
2018
-0.25(-85.4%)
2017
-1.71(+8.2%)
2016
-1.58(-80.7%)
2015
-8.19(-41.4%)
2014
-13.98(-20.0%)
2013
-17.48(+44.6%)
2012
-12.09

FAQ

  • What is Regulus Therapeutics EV/EBITDA?
  • What is the all time high EV/EBITDA for Regulus Therapeutics?
  • What is RGLS EV/EBITDA year-to-date change?
  • What is Regulus Therapeutics EV/EBITDA year-on-year change?

What is Regulus Therapeutics EV/EBITDA?

The current EV/EBITDA of RGLS is -1.62

What is the all time high EV/EBITDA for Regulus Therapeutics?

Regulus Therapeutics all-time high EV/EBITDA is 0.91

What is RGLS EV/EBITDA year-to-date change?

Regulus Therapeutics EV/EBITDA has changed by +0.27 (+14.29%) since the beginning of the year

What is Regulus Therapeutics EV/EBITDA year-on-year change?

Over the past year, RGLS EV/EBITDA has changed by -0.64 (-65.31%)